abagovomab
vanucizumab
ziltivekimab
retifanlimab
zenocutuzumab
ravulizumab
pozelimab
complement
crossreaction
immunochemistry
idiospecific
immunoproteomics
heteroclitic antibody
immunoaffinity
seroimmunity
immunosorbent
immunospecific
immunoantigen
horseradish peroxidase
antisynthetase
radioimmunoreactivity
target cell
talizumab
despeciation
heterophile
bivatuzumab
radioimmunoprecipitate
intetumumab
presentation
soravtansine
antisubstance
cibisatamab
immunoprobe
active immunity
monospecific
radioimmunoelectrophoresis
countercorrelated
immunocytic
xenoantibody
clenoliximab
amlitelimab
monoantibody
-mab
antimonoclonal
antihuman
glembatumumab
immunoadsorbent